Family-based association study between NOS-I and-IIA polymorphisms and autism spectrum disorders in korean trios

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 150, Issue 2, 2009, Pages 300-306

  Kim, Hyo Won ^a   Cho, Soo Churl ^a   Kim, Jae Won ^a   Cho, In Hee ^b   Kim, Soon Ae ^c   Park, Mira ^a,c   Cho, Eun Jeong ^d   Yoo, Hee Jeong ^a,e  

^a Seoul National University   (South Korea)

^b Gachon University College of Medicine   (South Korea)

^c Eulji University   (South Korea)

^d Asan Medical Center   (South Korea)

^e Seoul National University Bundang Hospital   (South Korea)

Author keywords

Association; Autism spectrum disorders (ASD); Candidate gene study; Nitric oxide synthase type I (NOS I); Nitric oxide synthase type IIA (NOS IIA)

Indexed keywords

NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE IIA; UNCLASSIFIED DRUG;

ARTICLE; AUTISM; DISEASE ASSOCIATION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HYPOXIA; MULTIPLE PREGNANCY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOTYPE; HAPLOTYPES; HUMANS; KOREA; MALE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 61449115868     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30798     Document Type: Article

References (41)

1. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. Washington, DC.
2. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, Rutter M. 1995. Autism as a strongly genetic disorder: Evidence from a British twin study. Psychol Med 25(1):63-77.
3. Bernstein HG, Bogerts B, Keilhoff G. 2005. The many faces of nitric oxide in schizophrenia. A review. Schizophr Res 78(1):69-86.
4. Black MD, Selk DE, Hitchcock JM, Wettstein JG, Sorensen SM. 1999. On the effect of neonatal nitric oxide synthase inhibition in rats: A potential neurodevelopmental model of schizophrenia. Neuropharmacology 38(9):1299-1306.
5. Brown GC, Bal-Price A. 2003. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 27(3):325-355.
6. Courchesne E, Pierce K. 2005. Why the frontal cortex in autism might be talking only to itself: Local over-connectivity but long-distance disconnection. Curr Opin Neurobiol 15(2):225-230.
7. DiCicco-Bloom E, Lord C, Zwaigenbaum L, Courchesne E, Dager SR, Schmitz C, Schultz RT, Crawley J, Young LJ. 2006. The developmental neurobiology of autism spectrum disorder. J Neurosci 26(26):6897-6906.
8. Freitag CM. 2007. The genetics of autistic disorders and its clinical relevance: A review of the literature. Mol Psychiatry 12(1):2-22.
9. Gillberg C. 2002. A guide to Asperger syndrome. New York: Cambridge University Press. p. 72-73.
10. Hancock DB, Martin ER, Fujiwara K, Stacy MA, Scott BL, Stajich JM, Jewett R, Li YJ, Hauser MA, Vance JM., et al. 2006. NOS2A and the modulating effect of cigarette smoking in Parkinson's disease. Ann Neurol 60(3):366-373.
11. Heneka MT, Dumitrescu L, Loschmann PA, Wullner U, Klockgether T. 2000. Temporal, regional, and cell-specific changes of iNOS expression after intrastriatal microinjection of interferon gamma and bacterial lipopolysaccharide. J Chem Neuroanat 18(4):167-179.
12. Heneka MT, Feinstein DL. 2001. Expression and function of inducible nitric oxide synthase in neurons. J Neuroimmunol 114(1-2):8-18.
13. Herken H, Uz E, Ozyurt H, Akyol O. 2001. Red blood cell nitric oxide levels in patients with schizophrenia. Schizophr Res 52(3):289-290.
14. Hughes JR. 2007. Autism: The first firm finding=underconnectivity? Epilepsy Behav 11(1):20-24.
15. KellerTA, KanaRK, JustMA. 2007. A developmental study of the structural integrity of white matter in autism. Neuroreport 18(1):23-27.
16. Kim SK, Kim OK. 2002. Korean vineland social maturity scale. Seoul: Chung-Ang Jeokseong Press.
17. Kolevzon A, Gross R, Reichenberg A. 2007. Prenatal and perinatal risk factors for autism: A review and integration of findings. Arch Pediatr Adolesc Med 161(4):326-333.
18. Lauritsen M, Ewald H. 2001. The genetics of autism. Acta Psychiatr Scand 103(6):411-427.
19. Lombard J. 1998. Autism: A mitochondrial disorder? Med Hypotheses 50(6):497-500.
20. Lord C, Risi S, Lambrecht L, Cook EH Jr, Leventhal BL, DiLavore PC, Pickles A, Rutter M. 2000. The autism diagnostic observation schedule-generic: A standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 30(3):205-223.
21. Lord C, Rutter M, Le Couteur A. 1994. Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24(5):659-685.
22. Lyons CR, Orloff GJ, Cunningham JM. 1992. Molecular cloning and functional expression of aninducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 267(9):6370-6374.
23. Minc-Golomb D, Tsarfaty I, Schwartz JP. 1994. Expression of inducible nitric oxide synthase by neurons following exposure to endotoxin and cytokine. Br J Pharmacol 112(3):720-722.
24. Pardo CA, Vargas DL, Zimmerman AW. 2005. Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry 17(6):485-495.
25. Park KS, Yoon JR, Park HJ, Park HJ, Kwon KO. 2002. Korean Educational Developmental Institute-Wechsler Intelligence Scale for Children (KEDI-WISC). Seoul:Korean Educational Development Institute.
26. Pickett J, London E. 2005. The neuropathology of autism: A review. J Neuropathol Exp Neurol 64(11):925-935.
27. Rutter M, Andersen-Wood L, Beckett C, Bredenkamp D, Castle J, Groothues C, Kreppner J, Keaveney L, Lord C, O'Connor TG. 1999. Quasi-autistic patterns following severe early global privation. English and Romanian Adoptees (ERA) Study Team. J Child Psychol Psychiatry 40(4):537-549.
28. Savas HA, Herken H, Yurekli M, Uz E, Tutkun H, Zoroglu SS, Ozen ME, Cengiz B, Akyol O. 2002. Possible role of nitric oxide and adreno-medullin in bipolar affective disorder. Neuropsychobiology 45(2):57-61.
29. Schulman H. 1997. Nitric oxide: A spatial second messenger. Mol Psychiatry 2(4):296-299.
30. Shen Y, Yu HM, Yuan TM, Gu WZ, Wu YD. 2007. Intrauterine infection induced oligodendrocyte injury and inducible nitric oxide synthase expression in the developing rat brain. J Perinat Med 35(3):203-209.
31. Siddhanta U, Presta A, Fan B, Wolan D, Rousseau DL, Stuehr DJ. 1998. Domain swapping in inducible nitric-oxide synthase. Electron transfer occurs between flavin and heme groups located on adjacent subunits in the dimer. J Biol Chem 273(30):18950-18958.
32. Simmons ML, Murphy S. 1992. Induction of nitric oxide synthase in glial cells. J Neurochem 59(3):897-905.
33. Small CI, Lyles GA, Breen KC. 2004. Inducible form of nitric oxide synthase expression in rat cortical neuronal cells in vitro. Neurobiol Dis 17(1):70-76.
34. Sweeten TL, Posey DJ, Shankar S, McDougle CJ. 2004. High nitric oxide production in autistic disorder: A possible role for interferon-gamma. Biol Psychiatry 55(4):434-437.
35. Tsuang MT. 2001. Defining alternative phenotypes for genetic studies: What can we learn from studies of schizophrenia? Am J Med Genet 105(1):8-10.
36. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. 2005. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57(1):67-81.
37. Xu W, Charles IG, Moncada S, Gorman P, Sheer D, Liu L, Emson P. 1994. Mapping ofthe genes encoding human inducible and endothelial nitric oxide synthase (NOS2 and NOS3) to the pericentric region ofchromosome 17 and to chromosome 7, respectively. Genomics 21(2):419-422.
38. Yonan AL, Alarcon M, Cheng R, Magnusson PK, Spence SJ, Palmer AA, Grunn A, Juo SH, Terwilliger JD, Liu J., et al. 2003. A genomewide screen of 345 families for autism-susceptibility loci. Am J Hum Genet 73(4):886-897.
39. Zhang J, Snyder SH. 1995. Nitric oxide in the nervous system. Annu Rev Pharmacol Toxicol 35:213-233.
40. Zhao P, Zuo Z. 2005. Prenatal hypoxia-induced adaptation and neuroprotection that is inducible nitric oxide synthase-dependent. Neurobiol Dis 20(3):871-880.
41. Zoroglu SS, Yurekli M, Meram I, Sogut S, Tutkun H, Yetkin O, Sivasli E, Savas HA, Yanik M, Herken H., et al. 2003. Pathophysiological role of nitric oxide and adrenomedullin in autism. Cell Biochem Funct 21(1):55-60.